Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Annovis Bio, Inc. (ANVS)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Annovis Bio, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Annovis Bio, Inc. since 2005.
The reporting company's ticker symbol is ANVS. The reporting company's CIK number is 1477845.
The total value of stock buying since 2005 is $714,420.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2020-02-03||Mcgroarty Jeffrey Brian (Chief Financial Officer)||Buy||19,500||7.16||139,620|
|2020-01-31||White Mark K. (Director)||Buy||1,734||6.00||10,404|
|2020-01-31||Bruck Claudine (Director)||Buy||800||6.00||4,800|
|2020-01-31||Mcgroarty Jeffrey Brian (Chief Financial Officer)||Buy||33,333||6.00||199,998|
|2020-01-31||Whelan, Jr. Robert M. (Director)||Buy||25,000||6.00||150,000|
|2020-01-31||Maccecchini Maria-luisa (President and CEO)||Buy||1,600||6.00||9,600|
|2020-01-31||Hoffman Michael B (Director)||Buy||33,333||6.00||199,998|
Insider trading activities including stock purchases, stock sales, and option exercises of ANVS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Annovis Bio, Inc. (symbol ANVS, CIK number 1477845) see the Securities and Exchange Commission (SEC) website.